From professional translators, enterprises, web pages and freely available translation repositories.
osi model
model osi
Last Update: 2006-09-06
Usage Frequency: 1
Quality:
model
vzorec
Last Update: 2017-04-06
Usage Frequency: 54
Quality:
(model)
(tip)
Last Update: 2014-11-21
Usage Frequency: 2
Quality:
osi information
druge informacije v zvezi s storitvami (osi)
Last Update: 2014-11-15
Usage Frequency: 1
Quality:
c. osi, 7
osi, 7
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
osi techniques, and
tehnike inšpekcijskih pregledov na kraju samem, in
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
osi-equipment; and
opreme za inšpekcije na kraju samem; in
Last Update: 2014-10-20
Usage Frequency: 1
Quality:
the equivalent iso and iso/iec standards for the osi model were available from iso, but only some of them without fees.
od leta 2005 je vojničev rokopis shranjen pod številko ms 408 v knjižnici "beinecke rare book and manuscript library" na univerzi yale, zda.
the value of msir technology for osi was reinforced during the msir test in hungary in september 2011.
pomen multispektralne in infrardeče tehnologije za inšpekcijske preglede na kraju samem se je po testiranju te tehnologije septembra 2011 na madžarskem še povečal.
for all of the endpoints described above, statistically significant results were also demonstrated in the osi population.
za vse zgoraj opisane opazovane dogodke so bili v 16. tednu rezultati statistično značilni tudi v populaciji osi.
* the osi's original legal counsel lawrence rosen has written a copyleft license, the open software license.
vendar pa imamo dokaz, da ga priznavata obe strani:* tako osi kot fsf imata copyleft in non-copyleft licence na njihovi listi licenc.
the primary metabolites osi-420 and osi-413 of erlotinib produced by o-demethylation of either side chain have comparable potency to erlotinib in non-clinical in vitro assays and in vivo tumour models.
primarna presnovka erlotiniba osi-420 in osi-413, ki nastaneta z o-demetiliranjem katere koli stranske verige, imata primerljivo učinkovitost z erlotinibom v nekliničnih in vitro metodah in in vivo tumorskih modelih.